Highlights

• The overall prevalence of malnutrition in diabetic patients was 33% (95% CI: 0.25–0.40), and the at-risk prevalence of malnutrition was 44% (95% CI: 0.34–0.54).
• Diabetic patients with malnutrition had significantly lower levels of body mass index, albumin, hemoglobin, triglyceride, and high-density lipoprotein cholesterol, while showing an increase in glycosylated hemoglobin.
• C-reactive protein >10 mg/L, age, duration of diabetes, Wagner grades 3–5, with cardiovascular disease, and using insulin were identified as risk factors for malnutrition in diabetic patients.

Highlights

• In this nationwide cohort study, initiating GLP-1 RA as the first-line treatment was associated with improved 1-year HbA1c levels compared with metformin.
• GLP-1 RA initiation was also associated with a lower risk of requiring additional glucose-lowering therapy; however, initial treatment adherence varied depending on the prediabetes or diabetes status.
• Overall, GLP-1 RAs as the first-line choice for 1-year outcomes may exhibit variability regarding treatment management based on prediabetes or diabetes status, but they generally result in improved glycemic control.

Highlights

• After the 34-year follow-up, increased TyG-BMI was independently associated with a higher risk of type 2 diabetes.
• TyG-BMI exhibited higher predictive ability than TyG or HOMA-IR in both short (6-year) and long terms (34-year). The best thresholds of TyG-BMI to predict diabetes were relatively stable (195.24–208.41).
• Our results provide the possibility to utilize TyG-BMI for predicting diabetes risk in clinical practice.

Highlights

• In people with diabetes mellitus, wearable technology-based physical activity interventions significantly increased daily steps and reduced systolic blood pressure.
• Intervention had a goal-setting component among T2DM patients, which had a greater effect on lowering BMI than their counterparts.
• In terms of BMI reduction, the year of publication was a significant covariate.

Highlights

• Elevated GA levels in serum were associated with stroke adverse outcomes.
• Adding GA into the conventional model resulted in slight improvements in predicting poor functional outcomes.
• The association between GA and poor functional outcomes was more pronounced in nondiabetic patients.

Highlights

• A clear association was observed between FBG levels and the risk of all-cause mortality in PD patients, indicating that FBG is a significant indicator for quantifying the risk of all-cause mortality in these patients.
• Although a higher FBG level was significantly associated with an increased risk of cardiovascular-related death, there was no notable increase in the risk of death from cancer or infections as the FBG levels increased.